Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC
Clinical trial NCT03326752 · COMPLETED
Trial details
- NCT number
- NCT03326752
- Sponsor
- Dynavax Technologies Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2019-09-19
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.